Global Contrast Media Injectors Market

Contrast Media Injectors Comprehensive Study by Type (MR injectors, CT injectors, Vascular injectors, Others), Application (Neurology, Cardiology, Oncology, Others), End-user (Hospitals, Ambulatory Surgical Centres, Diagnostics Centres) Players and Region - Global Market Outlook to 2027

Contrast Media Injectors Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Contrast Media Injectors
Contrast delivery injectors is defined as the therapeutic device which can be programmed in order to deliver specific measures of contrast agent at particular flow rates. It is also known as a power injector.It is used to inject contrast media in order to enhance the blood and perfusion in tissues. It is also widely used for use in computed tomography (CT) and magnetic resonance imaging (MRI). Increasing preference for minimally invasive procedures and increasing prevalence of chronic diseases owing to changing lifestyles are expected to drive the global contrast media injectors market growth. It is expected to expand at a CAGR of 5.2% from 2018 to 2026

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


Analyst at AMA Research estimates that China Players will contribute the maximum growth to Global Contrast Media Injectors market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Mallinckrodt Pharmaceuticals, (United Kingdom), Bracco Imaging S.p.A., (Italy), Medtron AG (Germany), Nemoto Kyorindo (China) and VIVID IMAGING (China) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Contrast Media Injectors market by Type (MR injectors, CT injectors, Vascular injectors and Others), Application (Neurology, Cardiology, Oncology and Others) and Region.



On the basis of geography, the market of Contrast Media Injectors has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-user, the sub-segment i.e. Hospitals will boost the Contrast Media Injectors market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2021, Bayer AG announced a collaboration with ArcherDX, Inc., which will focus on the global development and commercialization of a therapeutic companion diagnostic test, also known as a companion diagnostic (CDx) for Vitrakvi™ (larotrectinib), based on next-generation sequencing.
On 2014, Guerbet (France) Company had launched FlowSens, which is a syringe-free injection system composed of a soft bag injector as well as associated disposables, using a hydraulic, syringe-free injector to deliver contrast media. This product launched to help the company to expand its product portfolio and On September 2013, the Food and Drug Administration (United States) had announced Class 2 Device Recall of MEDRAD Stellant CT Injector System with Certegra due to an issue with the software design. It will help the growth of the market in the future.


Market Drivers
  • Increasing Demand for Minimally Invasive Surgeries
  • Growing Number of Regulatory Approvals
  • Injector’s Devices Along With Rising Regulatory Approvals
  • Increasing Number of Public and Private Diagnostic Centers

Opportunities
  • Growing Demand from Emerging Economics such as India, China and others
  • Increasing Focus of Market Players on Contrast Media Injector Arena

Restraints
  • High Cost of Contrast Media Injector and Adverse Effects of Contrast Agents
  • Reluctance of the Masses to the Use of Contrast Media Injectors
  • Risks Associated With Contrast Media Injectors
  • Reluctance to Adopt New Technology

Challenges
  • Lack of Awareness Regarding Contrast Media Injectors
  • Shortage of and Need for Highly Skilled Professionals
  • Development of Gamma and Neutron Imaging Solutions


Key Target Audience
Manufacturers of Contrast Media Injectors, Suppliers of Contrast Media Injectors, Wholesalers, Distributors and Retailers of Contrast Media Injectors, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • MR injectors
  • CT injectors
  • Vascular injectors
  • Others
By Application
  • Neurology
  • Cardiology
  • Oncology
  • Others
By End-user
  • Hospitals
  • Ambulatory Surgical Centres
  • Diagnostics Centres

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Minimally Invasive Surgeries
      • 3.2.2. Growing Number of Regulatory Approvals
      • 3.2.3. Injector’s Devices Along With Rising Regulatory Approvals
      • 3.2.4. Increasing Number of Public and Private Diagnostic Centers
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness Regarding Contrast Media Injectors
      • 3.3.2. Shortage of and Need for Highly Skilled Professionals
      • 3.3.3. Development of Gamma and Neutron Imaging Solutions
    • 3.4. Market Trends
      • 3.4.1. Increasing Technological Advancements in Contrast Media Injectors
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Contrast Media Injectors, by Type, Application, End-user and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Contrast Media Injectors (Value)
      • 5.2.1. Global Contrast Media Injectors by: Type (Value)
        • 5.2.1.1. MR injectors
        • 5.2.1.2. CT injectors
        • 5.2.1.3. Vascular injectors
        • 5.2.1.4. Others
      • 5.2.2. Global Contrast Media Injectors by: Application (Value)
        • 5.2.2.1. Neurology
        • 5.2.2.2. Cardiology
        • 5.2.2.3. Oncology
        • 5.2.2.4. Others
      • 5.2.3. Global Contrast Media Injectors by: End-user (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical Centres
        • 5.2.3.3. Diagnostics Centres
      • 5.2.4. Global Contrast Media Injectors Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Contrast Media Injectors: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mallinckrodt Pharmaceuticals, (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bracco Imaging S.p.A., (Italy)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtron AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Nemoto Kyorindo (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. VIVID IMAGING (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global Contrast Media Injectors Sale, by Type, Application, End-user and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Contrast Media Injectors (Value)
      • 7.2.1. Global Contrast Media Injectors by: Type (Value)
        • 7.2.1.1. MR injectors
        • 7.2.1.2. CT injectors
        • 7.2.1.3. Vascular injectors
        • 7.2.1.4. Others
      • 7.2.2. Global Contrast Media Injectors by: Application (Value)
        • 7.2.2.1. Neurology
        • 7.2.2.2. Cardiology
        • 7.2.2.3. Oncology
        • 7.2.2.4. Others
      • 7.2.3. Global Contrast Media Injectors by: End-user (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical Centres
        • 7.2.3.3. Diagnostics Centres
      • 7.2.4. Global Contrast Media Injectors Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Contrast Media Injectors: by Type(USD Million)
  • Table 2. Contrast Media Injectors MR injectors , by Region USD Million (2016-2021)
  • Table 3. Contrast Media Injectors CT injectors , by Region USD Million (2016-2021)
  • Table 4. Contrast Media Injectors Vascular injectors , by Region USD Million (2016-2021)
  • Table 5. Contrast Media Injectors Others , by Region USD Million (2016-2021)
  • Table 6. Contrast Media Injectors: by Application(USD Million)
  • Table 7. Contrast Media Injectors Neurology , by Region USD Million (2016-2021)
  • Table 8. Contrast Media Injectors Cardiology , by Region USD Million (2016-2021)
  • Table 9. Contrast Media Injectors Oncology , by Region USD Million (2016-2021)
  • Table 10. Contrast Media Injectors Others , by Region USD Million (2016-2021)
  • Table 11. Contrast Media Injectors: by End-user(USD Million)
  • Table 12. Contrast Media Injectors Hospitals , by Region USD Million (2016-2021)
  • Table 13. Contrast Media Injectors Ambulatory Surgical Centres , by Region USD Million (2016-2021)
  • Table 14. Contrast Media Injectors Diagnostics Centres , by Region USD Million (2016-2021)
  • Table 15. South America Contrast Media Injectors, by Country USD Million (2016-2021)
  • Table 16. South America Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 17. South America Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 18. South America Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 19. Brazil Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 20. Brazil Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 21. Brazil Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 22. Argentina Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 23. Argentina Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 24. Argentina Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 25. Rest of South America Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 26. Rest of South America Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 27. Rest of South America Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 28. Asia Pacific Contrast Media Injectors, by Country USD Million (2016-2021)
  • Table 29. Asia Pacific Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 30. Asia Pacific Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 31. Asia Pacific Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 32. China Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 33. China Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 34. China Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 35. Japan Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 36. Japan Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 37. Japan Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 38. India Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 39. India Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 40. India Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 41. South Korea Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 42. South Korea Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 43. South Korea Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 44. Taiwan Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 45. Taiwan Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 46. Taiwan Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 47. Australia Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 48. Australia Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 49. Australia Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 53. Europe Contrast Media Injectors, by Country USD Million (2016-2021)
  • Table 54. Europe Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 55. Europe Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 56. Europe Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 57. Germany Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 58. Germany Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 59. Germany Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 60. France Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 61. France Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 62. France Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 63. Italy Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 64. Italy Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 65. Italy Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 66. United Kingdom Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 67. United Kingdom Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 68. United Kingdom Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 69. Netherlands Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 70. Netherlands Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 71. Netherlands Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 72. Rest of Europe Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 73. Rest of Europe Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 74. Rest of Europe Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 75. MEA Contrast Media Injectors, by Country USD Million (2016-2021)
  • Table 76. MEA Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 77. MEA Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 78. MEA Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 79. Middle East Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 80. Middle East Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 81. Middle East Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 82. Africa Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 83. Africa Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 84. Africa Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 85. North America Contrast Media Injectors, by Country USD Million (2016-2021)
  • Table 86. North America Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 87. North America Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 88. North America Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 89. United States Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 90. United States Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 91. United States Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 92. Canada Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 93. Canada Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 94. Canada Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 95. Mexico Contrast Media Injectors, by Type USD Million (2016-2021)
  • Table 96. Mexico Contrast Media Injectors, by Application USD Million (2016-2021)
  • Table 97. Mexico Contrast Media Injectors, by End-user USD Million (2016-2021)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Contrast Media Injectors: by Type(USD Million)
  • Table 104. Contrast Media Injectors MR injectors , by Region USD Million (2022-2027)
  • Table 105. Contrast Media Injectors CT injectors , by Region USD Million (2022-2027)
  • Table 106. Contrast Media Injectors Vascular injectors , by Region USD Million (2022-2027)
  • Table 107. Contrast Media Injectors Others , by Region USD Million (2022-2027)
  • Table 108. Contrast Media Injectors: by Application(USD Million)
  • Table 109. Contrast Media Injectors Neurology , by Region USD Million (2022-2027)
  • Table 110. Contrast Media Injectors Cardiology , by Region USD Million (2022-2027)
  • Table 111. Contrast Media Injectors Oncology , by Region USD Million (2022-2027)
  • Table 112. Contrast Media Injectors Others , by Region USD Million (2022-2027)
  • Table 113. Contrast Media Injectors: by End-user(USD Million)
  • Table 114. Contrast Media Injectors Hospitals , by Region USD Million (2022-2027)
  • Table 115. Contrast Media Injectors Ambulatory Surgical Centres , by Region USD Million (2022-2027)
  • Table 116. Contrast Media Injectors Diagnostics Centres , by Region USD Million (2022-2027)
  • Table 117. South America Contrast Media Injectors, by Country USD Million (2022-2027)
  • Table 118. South America Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 119. South America Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 120. South America Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 121. Brazil Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 122. Brazil Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 123. Brazil Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 124. Argentina Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 125. Argentina Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 126. Argentina Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 127. Rest of South America Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 128. Rest of South America Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 129. Rest of South America Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 130. Asia Pacific Contrast Media Injectors, by Country USD Million (2022-2027)
  • Table 131. Asia Pacific Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 132. Asia Pacific Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 133. Asia Pacific Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 134. China Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 135. China Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 136. China Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 137. Japan Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 138. Japan Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 139. Japan Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 140. India Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 141. India Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 142. India Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 143. South Korea Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 144. South Korea Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 145. South Korea Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 146. Taiwan Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 147. Taiwan Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 148. Taiwan Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 149. Australia Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 150. Australia Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 151. Australia Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 152. Rest of Asia-Pacific Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 153. Rest of Asia-Pacific Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 154. Rest of Asia-Pacific Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 155. Europe Contrast Media Injectors, by Country USD Million (2022-2027)
  • Table 156. Europe Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 157. Europe Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 158. Europe Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 159. Germany Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 160. Germany Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 161. Germany Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 162. France Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 163. France Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 164. France Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 165. Italy Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 166. Italy Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 167. Italy Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 168. United Kingdom Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 169. United Kingdom Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 170. United Kingdom Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 171. Netherlands Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 172. Netherlands Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 173. Netherlands Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 174. Rest of Europe Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 175. Rest of Europe Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 176. Rest of Europe Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 177. MEA Contrast Media Injectors, by Country USD Million (2022-2027)
  • Table 178. MEA Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 179. MEA Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 180. MEA Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 181. Middle East Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 182. Middle East Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 183. Middle East Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 184. Africa Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 185. Africa Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 186. Africa Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 187. North America Contrast Media Injectors, by Country USD Million (2022-2027)
  • Table 188. North America Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 189. North America Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 190. North America Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 191. United States Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 192. United States Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 193. United States Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 194. Canada Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 195. Canada Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 196. Canada Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 197. Mexico Contrast Media Injectors, by Type USD Million (2022-2027)
  • Table 198. Mexico Contrast Media Injectors, by Application USD Million (2022-2027)
  • Table 199. Mexico Contrast Media Injectors, by End-user USD Million (2022-2027)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Contrast Media Injectors: by Type USD Million (2016-2021)
  • Figure 5. Global Contrast Media Injectors: by Application USD Million (2016-2021)
  • Figure 6. Global Contrast Media Injectors: by End-user USD Million (2016-2021)
  • Figure 7. South America Contrast Media Injectors Share (%), by Country
  • Figure 8. Asia Pacific Contrast Media Injectors Share (%), by Country
  • Figure 9. Europe Contrast Media Injectors Share (%), by Country
  • Figure 10. MEA Contrast Media Injectors Share (%), by Country
  • Figure 11. North America Contrast Media Injectors Share (%), by Country
  • Figure 12. Global Contrast Media Injectors share by Players 2021 (%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Mallinckrodt Pharmaceuticals, (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 15. Mallinckrodt Pharmaceuticals, (United Kingdom) Revenue: by Geography 2021
  • Figure 16. Bracco Imaging S.p.A., (Italy) Revenue, Net Income and Gross profit
  • Figure 17. Bracco Imaging S.p.A., (Italy) Revenue: by Geography 2021
  • Figure 18. Medtron AG (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Medtron AG (Germany) Revenue: by Geography 2021
  • Figure 20. Nemoto Kyorindo (China) Revenue, Net Income and Gross profit
  • Figure 21. Nemoto Kyorindo (China) Revenue: by Geography 2021
  • Figure 22. VIVID IMAGING (China) Revenue, Net Income and Gross profit
  • Figure 23. VIVID IMAGING (China) Revenue: by Geography 2021
  • Figure 24. Global Contrast Media Injectors: by Type USD Million (2022-2027)
  • Figure 25. Global Contrast Media Injectors: by Application USD Million (2022-2027)
  • Figure 26. Global Contrast Media Injectors: by End-user USD Million (2022-2027)
  • Figure 27. South America Contrast Media Injectors Share (%), by Country
  • Figure 28. Asia Pacific Contrast Media Injectors Share (%), by Country
  • Figure 29. Europe Contrast Media Injectors Share (%), by Country
  • Figure 30. MEA Contrast Media Injectors Share (%), by Country
  • Figure 31. North America Contrast Media Injectors Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Mallinckrodt Pharmaceuticals, (United Kingdom)
  • Bracco Imaging S.p.A., (Italy)
  • Medtron AG (Germany)
  • Nemoto Kyorindo (China)
  • VIVID IMAGING (China)
Select User Access Type

Key Highlights of Report


Jul 2022 151 Pages 50 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Contrast Media Injectors Market Quantitative research analysis
Global Contrast Media Injectors Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Mallinckrodt Pharmaceuticals, (United Kingdom), Bracco Imaging S.p.A., (Italy), Medtron AG (Germany), Nemoto Kyorindo (China) and VIVID IMAGING (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Technological Advancements in Contrast Media Injectors" is seen as one of major influencing trends for Contrast Media Injectors Market during projected period 2021-2027.
The Contrast Media Injectors market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Contrast Media Injectors Market Report?

Have a Query? Click Here

Other Related Reports

Neurophysiology Needles and Electrodes Comprehensive Study by Type (Needle Electrodes, Surface Electrodes, Cup Electrodes.), Application (EEG, EMG, TENS, Other), Distribution Chanel (Online, Offline)...
$ 3500
Auriscope Comprehensive Study by Type (Pocket, Full-Size, Video), Application (Hospitals, Clinics, Home Use, Others), Power Source (Hard-Wired, Battery Operated), Speculum Size (2 mm (New-Born), 3 mm...
$ 3350
Eye Instrument Comprehensive Study by Type (Cataract Surgery Devices, Glaucoma Surgery Devices, Refractive Surgery Devices, Vitreoretinal Surgery Devices, Ophthalmic Microscopes, Accessories), Applic...
$ 3650
Health Care Instrument Comprehensive Study by Type (Imaging Equipment, Advanced Modalities, Primary Modalities, Digital X-ray, Ultrasound, Endoscopic Devices, Surgical Instruments, Electromedical Equ...
$ 3750
Smart Exoskeleton Comprehensive Study by Type (Soft Exoskeleton, Rigid Exoskeleton), Technology (Pneumatic Actuator, Hydraulic, Electric Servo, Electric Actuator, Fully Mechanical, Shape Memory Alloy...
$ 3450
Medical Cooling Systems Comprehensive Study by Type (Water Cooled Chillers, Air Cooled Chillers, Others), Application (Medical Imaging, Medical Lasers, Medical Cold Storage and Testing, Healthcare De...
$ 3750